Literature DB >> 29424537

A New Bis(aquated) High Relaxivity Mn(II) Complex as an Alternative to Gd(III)-Based MRI Contrast Agent.

Bedika Phukan1, Chandan Mukherjee1, Upashi Goswami2, Amrit Sarmah3, Subhajit Mukherjee4, Suban K Sahoo5, Sankar Ch Moi4.   

Abstract

Disclosed here are a piperazine, a pyridine, and two carboxylate groups containing pentadentate ligand H2pmpa and its corresponding water-soluble Mn(II) complex (1). DFT-based structural optimization implied that the complex had pentagonal bipyramidal geometry where the axial positions were occupied by two water molecules, and the equatorial plane was constituted by the ligand ON3O donor set. Thus, a bis(aquated) disc-like Mn(II) complex has been synthesized. The complex showed higher stability compared with Mn(II)-EDTA complex [log KMnL = 14.29(3)] and showed a very high r1 relaxivity value of 5.88 mM-1 s-1 at 1.41 T, 25 °C, and pH = 7.4. The relaxivity value remained almost unaffected by the pH of the medium in the range of 6-10. Although the presence of 200 equiv of fluoride and bicarbonate anions did not affect the relaxivity value appreciably, an increase in the value was noticed in the presence of phosphate anion due to slow tumbling of the complex. Cell viability measurements, as well as phantom MR images using clinical MRI imager, consolidated the possible candidature of complex 1 as a positive contrast agent.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29424537     DOI: 10.1021/acs.inorgchem.7b03039

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  5 in total

1.  T1-T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents.

Authors:  Jingjing Li; Jia You; Chen Wu; Yue Dai; Meilin Shi; Lina Dong; Kai Xu
Journal:  Int J Nanomedicine       Date:  2018-08-10

2.  Tumor-targeted Gd-doped mesoporous Fe3O4 nanoparticles for T1/T2 MR imaging guided synergistic cancer therapy.

Authors:  Shaohui Zheng; Shang Jin; Min Jiao; Wenjun Wang; Xiaoyu Zhou; Jie Xu; Yong Wang; Peipei Dou; Zhen Jin; Changyu Wu; Jingjing Li; Xinting Ge; Kai Xu
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

3.  Molecular and Nano-Structural Optimization of Nanoparticulate Mn2+-Hexarhenium Cluster Complexes for Optimal Balance of High T1- and T2-Weighted Contrast Ability with Low Hemoagglutination and Cytotoxicity.

Authors:  Bulat Salavatovich Akhmadeev; Irek R Nizameev; Kirill V Kholin; Alexandra D Voloshina; Tatyana P Gerasimova; Aidar T Gubaidullin; Marsil K Kadirov; Ildus E Ismaev; Konstantin A Brylev; Rustem R Zairov; Asiya R Mustafina
Journal:  Pharmaceutics       Date:  2022-07-20       Impact factor: 6.525

Review 4.  Bioimaging agents based on redox-active transition metal complexes.

Authors:  Shan-Shan Xue; Yingbo Pan; Wei Pan; Shujie Liu; Na Li; Bo Tang
Journal:  Chem Sci       Date:  2022-07-27       Impact factor: 9.969

5.  Thermodynamic Stability of Mn(II) Complexes with Aminocarboxylate Ligands Analyzed Using Structural Descriptors.

Authors:  Rocío Uzal-Varela; Francisco Pérez-Fernández; Laura Valencia; Aurora Rodríguez-Rodríguez; Carlos Platas-Iglesias; Peter Caravan; David Esteban-Gómez
Journal:  Inorg Chem       Date:  2022-08-22       Impact factor: 5.436

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.